[Frequency of Re-incarcerations in the Same Detention Center: Role of Substitution Therapy. A Preliminary Retrospective Analysis]

Overview

Journal Ann Med Interne (Paris)

Specialty General Medicine

Date 2002 Sep 10

PMID 12218878

Citations 12

Authors

Ludovic Levasseur

Jean-Noel Marzo

Neil Ross

Catherine Blatier

Affiliations

Soon will be listed here.

Abstract

A retrospective study was carried out using 3 606 medical files of nine detention centers in France, over a three-month period (May to July 1997). The files were analyzed to determine, age, type of addiction and subsequent type of therapy proposed: methadone, high-dose buprenorphine or abstinence. A comparison was then made to determine whether or not there exists a statistical relationship between the type of therapy given in prison for drug abuse and subsequent recurrent use during the following three and a half years, until December 2000.

Citing Articles

Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for HIV-infected, opioid dependent prisoners and jail detainees who are transitioning to the community.

Di Paola A, Lincoln T, Skiest D, Desabrais M, Altice F, Springer S Contemp Clin Trials. 2014; 39(2):256-68.

PMID: 25240704 PMC: 4283549. DOI: 10.1016/j.cct.2014.09.002.

Ukrainian prisoners and community reentry challenges: implications for transitional care.

Morozova O, Azbel L, Grishaev Y, Dvoryak S, Wickersham J, Altice F Int J Prison Health. 2014; 9(1):5-19.

PMID: 25152767 PMC: 4138714. DOI: 10.1108/17449201311310760.

A randomized controlled trial of prison-initiated buprenorphine: prison outcomes and community treatment entry.

Gordon M, Kinlock T, Schwartz R, Fitzgerald T, OGrady K, Vocci F Drug Alcohol Depend. 2014; 142:33-40.

PMID: 24962326 PMC: 4129444. DOI: 10.1016/j.drugalcdep.2014.05.011.

Optimization of human immunodeficiency virus treatment during incarceration: viral suppression at the prison gate.

Meyer J, Cepeda J, Wu J, Trestman R, Altice F, Springer S JAMA Intern Med. 2014; 174(5):721-9.

PMID: 24687044 PMC: 4074594. DOI: 10.1001/jamainternmed.2014.601.

Medication-assisted treatment research with criminal justice populations: challenges of implementation.

Gordon M, Kinlock T, Miller P Behav Sci Law. 2011; 29(6):829-45.

PMID: 22086665 PMC: 3243915. DOI: 10.1002/bsl.1015.